Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity
Anna C.C. Aguiar, Erika Murce, Wilian A. Cortopassi and 6 more
International Journal for Parasitology: Drugs and Drug Resistance · 2018
doi:10.1016/j.ijpddr.2018.10.002 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
In spite of recent efforts to eradicate malaria in the world, this parasitic disease is still considered a major public health problem, with a total of 216 million cases of malaria and 445,000 deaths in 2016. Artemisinin-based combination therapies remain effective in most parts of the world, but recent cases of resistance in Southeast Asia have urged for novel approaches to treat malaria caused by Plasmodium falciparum. In this work, we present chloroquine analogs that exhibited high activity against sensitive and chloroquine-resistant P. falciparum blood parasites and were also active against P. berghei infected mice. Among the compounds tested, DAQ, a chloroquine analog with a more linear side chain, was shown to be the most active in vitro and in vivo, with low cytotoxicity, and therefore may serve as the basis for the development of more effective chloroquine analogs to aid malaria eradication. Keywords: Malaria, Chloroquine, Resistance, Drug design
Abstract licence: CC BY-NC-ND
Cited by papers we hold3
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.